Bone Graft Materials Observational Registry
- Conditions
- Spinal StenosisSpinal DeformityHerniated DiscCervical MyelopathyFailed Back Surgery SyndromeSpinal Cord NeoplasmsDegenerative Disc DiseaseSpondylolithesis
- Interventions
- Device: Bone graft substitute, autograft or allograft
- Registration Number
- NCT00974623
- Lead Sponsor
- Baxter Healthcare Corporation
- Brief Summary
A multi-center, prospective, observational patient registry to collect information on the clinical outcomes and "real world" use of approved and commercially available bone graft substitutes, autograft and allograft.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 329
- The patient has failed conservative treatment and is a candidate for spinal fusion surgery.
- The patient is ≥18 years old and of legal age of consent.
- The patient is, in the investigator's opinion, psychosocially, mentally, and physically able to fully comply with this protocol, including the post-operative regimen, required follow-up visits, the filling out of required forms, and have the ability to understand and give written informed consent.
- The patient is skeletally mature (epiphyses closed).
- The patient has signed the IRB approved informed consent.
- The patient is willing and able to participate in post-operative clinical and radiographic follow up evaluations for 2 years.
- Patient has systemic infection or infection at the surgical site.
- Patient has a medical condition that would interfere with post-operative assessments and care (i.e., neuromuscular disease, psychiatric disease, paraplegia, quadriplegia, etc.).
- Patient is in poor general health or any concurrent disease process that would place the patient in excessive risk to surgery (i.e., significant circulatory or pulmonary problems, or cardiac disease).
- Patient has a history (present or past) of substance abuse (recreational drugs, prescription drugs or alcohol) that in the investigator's opinion may interfere with protocol assessments and/or with the patient's ability to complete the protocol required follow-up.
- The patient is pregnant/breastfeeding at the time of enrollment, or plans to become pregnant during the course of the study.
- Patient is participating in another investigational study, which could confound results.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Spinal Fusion Bone graft substitute, autograft or allograft Patients who undergo a planned spinal fusion procedure requiring approved bone grafting materials (e.g., bone grft substitutes, allograft or autograft).
- Primary Outcome Measures
Name Time Method Evidence of successful radiographic fusion 6 months, 12 months & 24 months
- Secondary Outcome Measures
Name Time Method Improvement of pain/function in comparison to pre-operative QOL scores 6 months, 12 months & 24 months Maintenance or improvement in neurological status, as compared to baseline scores 6 months 12 months & 24 months
Trial Locations
- Locations (14)
Arthritis & Joint Center - U. Mass. Memorial
🇺🇸Worcester, Massachusetts, United States
PRESSD
🇺🇸Southfield, Michigan, United States
Montana Neuroscience Institute Foundation
🇺🇸Missoula, Montana, United States
St. Joseph's Hospital - Resurgeons Orthopedics
🇺🇸Atlanta, Georgia, United States
Bluegrass Orthopedics & Hand Care Research
🇺🇸Lexington, Kentucky, United States
Carrollton Orthopedics
🇺🇸Carrollton, Georgia, United States
Henry Ford West Bloomfield Hospital
🇺🇸West Bloomfield, Michigan, United States
Syracuse Orthopedic Specialists
🇺🇸Syracuse, New York, United States
Brain & Spine of Texas
🇺🇸Plano, Texas, United States
Buda Health Center
🇭🇺Budapest, Hungary
UCSF
🇺🇸San Francisco, California, United States
Physicians Research Options Spine Center
🇺🇸Las Vegas, Nevada, United States
Neurosurgical Associates
🇺🇸Nashville, Tennessee, United States
Isala Klinieken
🇳🇱Groot Wezenland, Zwolle, Netherlands